78 related articles for article (PubMed ID: 17046098)
1. Paternity leave in Sweden: costs, savings and health gains.
Månsdotter A; Lindholm L; Winkvist A
Health Policy; 2007 Jun; 82(1):102-15. PubMed ID: 17046098
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
3. Smoking, healthcare cost, and loss of productivity in Sweden 2001.
Bolin K; Lindgren B
Scand J Public Health; 2007; 35(2):187-96. PubMed ID: 17454923
[TBL] [Abstract][Full Text] [Related]
4. A cost-effectiveness analysis of alcohol prevention targeting licensed premises.
Månsdotter AM; Rydberg MK; Wallin E; Lindholm LA; Andréasson S
Eur J Public Health; 2007 Dec; 17(6):618-23. PubMed ID: 17387105
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
Borg S; Glenngård AH; Osterborg A; Persson U
Acta Oncol; 2008; 47(6):1009-17. PubMed ID: 18770060
[TBL] [Abstract][Full Text] [Related]
6. Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.
Lindgren P; Geborek P; Kobelt G
Int J Technol Assess Health Care; 2009 Apr; 25(2):181-9. PubMed ID: 19331709
[TBL] [Abstract][Full Text] [Related]
7. Who takes paternity leave? A cohort study on prior social and health characteristics among fathers in Stockholm.
Månsdotter A; Fredlund P; Hallqvist J; Magnusson C
J Public Health Policy; 2010 Sep; 31(3):324-41. PubMed ID: 20805805
[TBL] [Abstract][Full Text] [Related]
8. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
9. Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
Bolin K; Mörk AC; Willers S; Lindgren B
Respir Med; 2008 May; 102(5):699-710. PubMed ID: 18289839
[TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of a community-based diabetes prevention program in Sweden.
Johansson P; Ostenson CG; Hilding AM; Andersson C; Rehnberg C; Tillgren P
Int J Technol Assess Health Care; 2009 Jul; 25(3):350-8. PubMed ID: 19619354
[TBL] [Abstract][Full Text] [Related]
11. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of treatment with epoietin-alpha for patients with anaemia due to renal failure: the case of Sweden.
Glenngård AH; Persson U; Schön S
Scand J Urol Nephrol; 2008; 42(1):66-73. PubMed ID: 17907051
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin.
Lindgren P; Graff J; Olsson AG; Pedersen TJ; Jönsson B;
Eur Heart J; 2007 Jun; 28(12):1448-53. PubMed ID: 17371782
[TBL] [Abstract][Full Text] [Related]
14. Preventive home visits to older people are cost-effective.
Sahlen KG; Löfgren C; Mari Hellner B; Lindholm L
Scand J Public Health; 2008 May; 36(3):265-71. PubMed ID: 18519295
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
16. Dangerous dads? Ecological and longitudinal analyses of paternity leave and risk for child injury.
Laflamme L; Månsdotter A; Lundberg M; Magnusson C
J Epidemiol Community Health; 2012 Nov; 66(11):1001-4. PubMed ID: 22245721
[TBL] [Abstract][Full Text] [Related]
17. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden.
Kasteng F; Erlanson M; Hagberg H; Kimby E; Relander T; Lundkvist J
Acta Oncol; 2008; 47(6):1029-36. PubMed ID: 18607857
[TBL] [Abstract][Full Text] [Related]
19. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
